NORMAL BREAST EPITHELIAL-CELLS PRODUCE INTERLEUKIN-6 AND INTERLEUKIN-8 TOGETHER WITH TUMOR-NECROSIS-FACTOR - DEFECTIVE IL6 EXPRESSION IN MAMMARY-CARCINOMA

被引:82
作者
BASOLO, F
CONALDI, PG
FIORE, L
CALVO, S
TONIOLO, A
机构
[1] UNIV PAVIA, INST MED & PUBL HLTH, VIALE BORRI 57, I-21100 VARESE, ITALY
[2] UNIV PISA, INST PATHOL ANAT, I-56100 PISA, ITALY
关键词
D O I
10.1002/ijc.2910550609
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Virtually pure primary cultures of normal mammary epithelial cells (MEC) obtained from healthy women were shown to release interleukin 6 and 8 (IL6, IL8) and to produce a non-secreted form of tumor-necrosis factor (TNF). No interferon (IFN), whether alpha, beta or gamma, or IL1-alpha or -beta could be detected. Analysis of cellular RNA confirmed these findings and showed that MEC also express IL6 receptor and TNF-alpha-related mRNAs. Epithelial cells were selectively stained by antibodies to IL6, IL8 and TNF-alpha both in primary cultures and in the normal mammary gland. Samples of human milk contained sizable amounts of IL6, IL8 and IFN-gamma; yet the liquid phase was consistently negative for other cytokines (i.e., TNF-alpha, IFN-alpha/-beta, IL1-alpha/-beta). Expression of IL6 (but not of IL8 and TNF-alpha) was abolished in ductal infiltrating carcinomas and greatly reduced in cultures of oncogene-transfected mammary cells, suggesting that alterations of IL6 expression are associated with pathogenesis in breast cancer. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:926 / 930
页数:5
相关论文
共 14 条
[1]  
Akira S, 1992, Semin Cancer Biol, V3, P17
[2]  
BAGLIONI C, 1992, TUMOR NECROSIS FACTO, P425
[3]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[4]   REGULATION OF SURFACE-DIFFERENTIATION MOLECULES BY EPIDERMAL GROWTH-FACTOR, TRANSFORMING GROWTH-FACTOR ALPHA, AND HYDROCORTISONE IN HUMAN MAMMARY EPITHELIAL-CELLS TRANSFORMED BY AN ACTIVATED C-HA-RAS PROTOONCOGENE [J].
BASOLO, F ;
SERRA, C ;
CIARDIELLO, F ;
FIORE, L ;
RUSSO, J ;
CAMPANI, D ;
DOLEI, A ;
SQUARTINI, F ;
TONIOLO, A .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (04) :634-640
[5]   GROWTH-INHIBITION OF HUMAN-BREAST CARCINOMA AND LEUKEMIA LYMPHOMA CELL-LINES BY RECOMBINANT INTERFERON-BETA-2 [J].
CHEN, L ;
MORY, Y ;
ZILBERSTEIN, A ;
REVEL, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :8037-8041
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]  
DIXON RB, 1991, SEMIN ONCOL, V19, P286
[8]  
HIRANO T, 1992, CHEM IMMUNOL, V51, P153
[9]  
MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236
[10]  
MESTECKY J, 1991, ADV EXP MED BIOL, V310, P1